| scholarly article | Q13442814 |
| P50 | author | John Collinge | Q21165693 |
| Sarah J. Tabrizi | Q24039464 | ||
| Jonathan Wadsworth | Q67979357 | ||
| P2093 | author name string | Sebastian Brandner | |
| Peter-Christian Klöhn | |||
| Mark Kristiansen | |||
| Marcus J Messenger | |||
| P433 | issue | 46 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| prion protein family | Q24724413 | ||
| P304 | page(s) | 38851-38861 | |
| P577 | publication date | 2005-09-12 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis | |
| P478 | volume | 280 |
| Q38635898 | Abnormal calcium homeostasis and protein folding stress at the ER: A common factor in familial and infectious prion disorders |
| Q33757230 | Aggresome formation is regulated by RanBPM through an interaction with HDAC6 |
| Q33378239 | Aggresomes do not represent a general cellular response to protein misfolding in mammalian cells |
| Q39236165 | Alteration of NF-kappaB activity leads to mitochondrial apoptosis after infection with pathological prion protein |
| Q41775371 | Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane |
| Q42416416 | Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP. |
| Q33742065 | Cell type-specific neuroprotective activity of untranslocated prion protein |
| Q36981826 | Cytosolic caspases mediate mislocalised SOD2 depletion in an in vitro model of chronic prion infection. |
| Q36985644 | Diminishing apoptosis by deletion of Bax or overexpression of Bcl-2 does not protect against infectious prion toxicity in vivo |
| Q43189338 | Direct detection of disease associated prions in brain and lymphoid tissue using antibodies recognizing the extreme N terminus of PrPC. |
| Q34167039 | Direct evidence of generation and accumulation of β-sheet-rich prion protein in scrapie-infected neuroblastoma cells with human IgG1 antibody specific for β-form prion protein |
| Q36403528 | Effect of divalent metals on the neuronal proteasomal system, prion protein ubiquitination and aggregation. |
| Q39474448 | Functional genomics approach for identification of molecular processes underlying neurodegenerative disorders in prion diseases |
| Q37097991 | Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study |
| Q33347355 | Genomic and post-genomic analyses of human prion diseases |
| Q30492360 | Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions |
| Q33408776 | HECTD2 is associated with susceptibility to mouse and human prion disease |
| Q37258075 | Identification of novel SHPS-1-associated proteins and their roles in regulation of insulin-like growth factor-dependent responses in vascular smooth muscle cells |
| Q33296885 | In vitro and in vivo neurotoxicity of prion protein oligomers. |
| Q40286037 | Increased Src kinase level results in increased protein tyrosine phosphorylation in scrapie-infected neuronal cell lines |
| Q38085466 | Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration |
| Q39748724 | Intracellular distribution of p300 and its differential recruitment to aggresomes in breast cancer |
| Q33744702 | Low density subcellular fractions enhance disease-specific prion protein misfolding |
| Q38800950 | Mechanisms of prion-induced neurodegeneration. |
| Q35177001 | Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry |
| Q36731464 | Molecular basis of cerebral neurodegeneration in prion diseases. |
| Q37462236 | Molecular pathology of human prion diseases |
| Q33581647 | Perturbation of endoplasmic reticulum homeostasis facilitates prion replication. |
| Q26825056 | Potential roles for prions and protein-only inheritance in cancer |
| Q38316783 | Prion degradation pathways: Potential for therapeutic intervention |
| Q37075786 | Prion diseases: from protein to cell pathology |
| Q42510590 | Prion protein aggregation and neurotoxicity in cortical neurons |
| Q33786940 | Prion protein misfolding affects calcium homeostasis and sensitizes cells to endoplasmic reticulum stress |
| Q36578308 | Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system |
| Q38166717 | Prions Ex Vivo: What Cell Culture Models Tell Us about Infectious Proteins |
| Q36628157 | Prions and their partners in crime |
| Q54224345 | Prions, prionoids and protein misfolding disorders. |
| Q30481841 | Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation |
| Q28577028 | Pronounced cytosolic aggregation of cellular prion protein in pancreatic beta-cells in response to hyperglycemia |
| Q35311053 | Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein |
| Q24654152 | Proteasome inhibition by fellutamide B induces nerve growth factor synthesis |
| Q38793449 | Protein Quality Control in Health and Disease |
| Q34299594 | Protein disulfide isomerase regulates endoplasmic reticulum stress and the apoptotic process during prion infection and PrP mutant-induced cytotoxicity |
| Q35714147 | Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells |
| Q37978890 | Quality control compartments coming of age. |
| Q39556052 | Rapid cell-surface prion protein conversion revealed using a novel cell system |
| Q34999535 | Recent advances in our understanding of neurodegeneration |
| Q38211846 | Regulation of proteasomes in prion disease |
| Q40034009 | Resistance of cell lines to prion toxicity aided by phospho-ERK expression |
| Q28538070 | Solvent microenvironments and copper binding alters the conformation and toxicity of a prion fragment |
| Q36393488 | Stressing out the ER: a role of the unfolded protein response in prion-related disorders |
| Q37562694 | Stressing the ubiquitin-proteasome system |
| Q39145994 | The Emerging Roles of Early Protein Folding Events in the Secretory Pathway in the Development of Neurodegenerative Maladies |
| Q40305093 | The interaction between cytoplasmic prion protein and the hydrophobic lipid core of membrane correlates with neurotoxicity |
| Q24644208 | The ubiquitin proteasome system in neuropathology |
| Q33980214 | The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution |
| Q28386906 | The ubiquitin-proteasome system in spongiform degenerative disorders |
| Q38341877 | Trafficking and degradation pathways in pathogenic conversion of prions and prion-like proteins in neurodegenerative diseases |
| Q33769602 | Transcriptional analysis implicates endoplasmic reticulum stress in bovine spongiform encephalopathy |
| Q26773443 | Unfolded Protein Response and Macroautophagy in Alzheimer's, Parkinson's and Prion Diseases |
Search more.